Loading
อ. อัญชลี เตชะเสน

อ. อัญชลี เตชะเสน

สายวิชาเทคนิคการแพทย์,
คณะเทคนิคการแพทย์,
มหาวิทยาลัยขอนแก่น
35977270400: H-INDEX 20

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Eri Takahashi
Eiji Sugihara
Anucha Puapairoj
Masanao Miwa
Hideyuki Saya
Puangrat Yongvanit
2010
2. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011
3. Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. Jurairat Jongthawin
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
2012
4. Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells Techasen, A
Loilome, W
Namwat, N
Dokduang, H
Jongthawin, J
Yongvanit, P
2012
5. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma N. Namwat
P. Chusorn
W. Loilome
A. Techasen
J. Puetkasichonpasutha
C. Pairojkul
N. Khuntikeo
P. Yongvanit
2012
6. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. Watcharin Loilome
Sasithorn Kadsanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Ananya Dechakhamphu
Chadamas Pinitsoontorn
Puangrat Yongvanit
2012
7. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Puangrat Yongvanit
Raynoo Thanan
Somchai Pinlaor
Paiboon Sithithaworn
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Somkid Dechakhamphu
2012
8. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. Techasen, A.
Loilome, W.
Namwat, N.
Duenngai, K.
Cha'on, U.
Thanan, R.
Sithithaworn, P.
Miwa, M.
Yongvanit, P.
2012
9. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Pornpan Bungkanjana
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2012
10. Annexin A1: A new immunohistological marker of cholangiocarcinoma Hongsrichan, N
Rucksaken, R
Chamgramol, Y
Pinlaor, P
Techasen, A
Yongvanit, P
Khuntikeo, N
Pairojkul, C
Pinlaor, S
2013
11. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. Apinya Jusakul
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Rahul Kuver
George N. Ioannou
Christopher Savard
W. Geoffrey Haigh
Puangrat Yongvanit
2013
12. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Yothaisong, S
Dokduang, H
Techasen, A
Namwat, N
Yongvanit, P
Bhudhisawasdi, V
Puapairoj, A
Riggins, GJ
Loilome, W
2013
13. Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model Hasaya Dokduang
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Chawalit Pairojkul
Narong Khuntikeo
Yoshinori Murakami
Puangrat Yongvanit
2013
14. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
A. Dechakhamphu
C. Talabnin
W. Chan-On
C. K. Ong
B. T. Teh
P. Yongvanit
2013
15. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Jamnongkan, W.
Techasen, A.
Thanan, R.
Duenngai, K.
Sithithaworn, P.
Mairiang, E.
Loilome, W.
Namwat, N.
Pairojkul, C.
Yongvanit, P.
2013
16. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. Hasaya Dokduang
Sirinun Juntana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Gregory J. Riggins
Watcharin Loilome
2013
17. The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma Jurairat Jongthawin
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Chavalit Pairojkul
Narong Khuntikeo
Nisana Namwat
2013
18. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells Watcharin Loilome
Pornpan Bungkanjana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Anucha Puapairoj
Narong Khuntikeo
Gregory J. Riggins
2014
19. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Khenjanta, C.
Thanan, R.
Jusakul, A.
Techasen, A.
Jamnongkan, W.
Namwat, N.
Loilome, W.
Pairojkul, C.
Yongvanit, P.
2014
20. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma Duangkumpha, K
Techasen, A
Loilome, W
Namwat, N
Thanan, R
Khuntikeo, N
Yongvanit, P
2014
21. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Porncheera Chusorn
Anchalee Techasen
Thidarut Boonmars
Narong Khuntikeo
Nittaya Chamadol
Chawalit Pairojkul
Nisana Namwat
2014
22. Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression Yingpinyapat Kittirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
23. Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
24. Gene Silencing of Translationally Controlled Tumor Protein (TCTP) Nattaporn Phanthaphol
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
25. Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. Miwa, M
Honjo, S
You, G
Tanaka, M
Uchida, K
Srivatanakul, P
Khuhaprema, T
Loilome, W
Techasen, A
Wongkham, C
Limpaiboon, T
Yongvanit, P
Wongkham, S
2014
26. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014
27. Increased EphB2 expression predicts cholangiocarcinoma metastasis Khansaard, W
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Loilome, W
2014
28. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Techasen, A.
Loilome, W.
Namwat, N.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2014
29. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014
30. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Chawalit Pairojkul
Yoshinori Murakami
Watcharin Loilome
Puangrat Yongvanit
2014
31. Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment W. Loilome
H. Dokduang
S. Yothaisong
P. Bungkanjana
S. Juntana
A. Techasen
N. Namwat
P. Yongvanit
N. Khuntikeo
A. Puapairoj
2014
32. TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
B. Tean Teh
I. Lee
P. Yongvanit
2014
33. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. Techasen, A.
Namwat, N.
Loilome, W.
Duangkumpha, K.
Puapairoj, A.
Saya, H.
Yongvanit, P.
2014
34. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. Chanika Worasith
Christine Kamamia
Anna Yakovleva
Kunyarat Duenngai
Chompunoot Wangboon
Jiraporn Sithithaworn
Nattaya Watwiengkam
Nisana Namwat
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Alex Loukas
Paiboon Sithithaworn
Jeffrey M. Bethony
2015
35. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells Thongchot, S
Loilome, W
Yongvanit, P
Dokduang, H
Thanan, R
Techasen, A
Namwat, N
2015
36. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis Thanan, R.
Techasen, A.
Hou, B.
Jamnongkan, W.
Armartmuntree, N.
Yongvanit, P.
2015
37. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wattanawongdon, W
Hahnvajanawong, C
Namwat, N
Kanchanawat, S
Boonmars, T
Jearanaikoon, P
Leelayuwat, C
Techasen, A
Seubwai, W
2015
38. Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis Thanee, M
Loilome, W
Techasen, A
Namwat, N
Boonmars, T
Pairojkul, C
Yongvanit, P
2015
39. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. Nichapavee Nutthasirikul
Chariya Hahnvajanawong
Anchalee Techasen
Temduang Limpaiboon
Chanvit Leelayuwat
Siri Chau-In
Patcharee Jearanaikoon
2015
40. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Eiji Sugihara
Shogo Okazaki
Shinya Abe
Shiho Ueda
Takashi Masuko
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Chawalit Pairojkul
Hideyuki Saya
Puangrat Yongvanit
2016
41. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Chua-On, D
Proungvitaya, T
Techasen, A
Limpaiboon, T
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sungkhamanon, S
Proungvitaya, S
2016
42. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. Xurui Dai
Suyanee Thongchot
Hasaya Dokduang
Watcharin Loilome
Narong Khuntikeo
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Anchalee Techasen
Nisana Namwat
2016
43. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Loilome, W.
Yongvanit, P.
Namwat, N.
Techasen, A.
Khuntikeo, N.
2017
44. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017
45. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem Hughes, T
O'Connor, T
Techasen, A
Namwat, N
Loilome, W
Andrews, RH
Khuntikeo, N
Yongvanit, P
Sithithaworn, P
Taylor-Robinson, SD
2017
46. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Armartmuntree, N
Murata, M
Techasen, A
Yongvanit, P
Loilome, W
Namwat, N
Pairojkul, C
Sakonsinsiri, C
Pinlaor, S
Thanan, R
2017
47. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Manida Suksawat
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Supinda Koonmee
Watcharin Loilome
2017
48. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017
49. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool Jamnongkan, W
Thanan, R
Techasen, A
Namwat, N
Loilome, W
Intarawichian, P
Titapun, A
Yongvanit, P
2017
50. Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool Wassana Jamnongkan
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Piyapharom Intarawichian
Attapol Titapun
Puangrat Yongvanit
2017
51. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Suyanee Thongchot
Paiboon Sithithaworn
Thidarut Boonmars
Supinda Koonmee
Attapol Titapun
Narong Khuntikeo
Nittaya Chamadol
Anchalee Techasen
Nisana Namwat
2017
52. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. Jamnongkan, W.
Thanee, M.
Yongvanit, P.
Loilome, W.
Thanan, R.
Namwat, N.
Techasen, A.
2018
53. CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Nisana Namwat
Attapon Titapun
Narong Khuntikeo
Shogo Okazaki
Eiji Sugihara
Hideyuki Saya
Puangrat Yongvanit
2018
54. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. Chatanun Eamudomkarn
Paiboon Sithithaworn
Christine Kamamia
Anna Yakovleva
Jiraporn Sithithaworn
Sasithorn Kaewkes
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Chompunoot Wangboon
Prasert Saichua
Makoto Itoh
Jeffrey M. Bethony
2018
55. Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis Anchalee Techasen
Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
2018
56. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. Wangboon, C
Worasith, C
Thanan, R
Eamudomkarn, C
Techasen, A
Sithithaworn, J
Loilome, W
Chamadol, N
Pinlaor, S
Jumnainsong, A
Yongvanit, P
Khuntikeo, N
Bethony, JM
Sithithaworn, P
2018
57. Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development Sasikamon Korphai
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
2018
58. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy Suksawat, M
Techasen, A
Namwat, N
Boonsong, T
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Loilome, W
2018
59. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018
60. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018
61. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Dokduang, H.
Yothaisong, S.
Techasen, A.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Loilome,
2018
62. Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018
63. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018
64. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Thongchot, S.
Loilome,
Techasen, A.
Ungarreevittaya, P.
Khuntikeo, N.
Yongvanit, P.
2018
65. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. Minerva Daya
Watcharin Loilome
Anchalee Techasen
Malinee Thanee
Prakasit Sa-Ngiamwibool
Attapol Titapun
Puangrat Yongvanit
Nisana Namwat
2018
66. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018
67. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine Techasen, A.
Thongchot, S.
Loilome, W.
Thanan, R.
Yongvanit, P.
Titapun, A.
Khuntikeo, N.
Namwat, N.
2018
68. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018
69. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018
70. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018
71. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway Khophai, S
Thanee, M
Techasen, A
Namwat, N
Klanrit, P
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Loilome, W
2018
72. ZNF423 expression in relation to oxidative stress-induced CCA progression Timpika Chaiprasert
Napat Armartmuntree
Chadamas Sakonsinsiri
Somchai Pinlaor
Anchalee Techasen
Raynoo Thanan
2018
73. Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols Eamudomkarn, C.
Techasen, A.
Sithithaworn, J.
Itoh, M.
Sithithaworn, P.
2019
74. Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Worasith, C
Wangboon, C
Duenngai, K
Kiatsopit, N
Kopolrat, K
Techasen, A
Sithithaworn, J
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Carlton, EJ
Sithithaworn, P
2019
75. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019
76. Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma Jamnongkan, W.
Techasen, A.
Loilome,
Sithithaworn, P.
Khuntikeo, N.
Pairojkul, C.
Chamadol, N.
Thanan, R.
Yongvanit, P.
2019
77. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Promraksa, B
Phetcharaburanin, J
Namwat, N
Techasen, A
Boonsiri, P
Loilome, W
2019
78. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG Chompunoot Wangboon
Chanika Worasith
Raynoo Thanan
Chatanun Eamudomkarn
Anchalee Techasen
Jiraporn Sithithaworn
Watcharin Loilome
Nittaya Chamadol
Somchai Pinlaor
Amonrat Jumnainsong
Puangrat Yongvanit
Narong Khuntikeo
Jeffrey M. Bethony
Paiboon Sithithaworn
2019
79. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Suksawat, M
Klanrit, P
Phetcharaburanin, J
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Techasen, A
Loilome, W
2019
80. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress Armartmuntree, N.
Techasen, A.
Sakonsinsiri, C.
Pinlaor, S.
Ungarreevittaya, P.
Khuntikeo, N.
Thanan, R.
2019
81. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019
82. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Taron, W
Jamnongkan, W
Techasen, A
Phetcharaburanin, J
Namwat, N
Sithithaworn, P
Khuntikeo, N
Mukdasai, S
Sayasone, S
Loilome, W
Ngeontae, W
2020
83. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. Kimawaha, P
Jusakul, A
Junsawang, P
Loilome, W
Khuntikeo, N
Techasen, A
2020
84. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Thongchot, S.
Thanee, M.
Loilome, W.
Techasen, A.
Titapun, A.
Yongvanit, P.
Namwat, N.
2020
85. Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression Raynoo Thanan
Waleeporn Kaewlert
Chadamas Sakonsinsiri
Timpika Chaiprasert
Napat Armartmuntree
Duangkamon Muengsaen
Anchalee Techasen
Poramate Klanrit
Worachart Lert-itthiporn
Somchai Pinlaor
Chawalit Pairojkul
2020
Count 60 59 69 4

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Techasen, A.
Loilome, W.
Namwat, N.
Takahashi, E.
Puapairoj, A.
Miwa, M.
Saya, H.
Yongvanit, P.
2010 Cancer Science
3 (101), pp. 658-665
2. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases Namwat, N.
Puetkasichonpasutha, J.
Loilome, W.
Yongvanit, P.
Techasen, A.
Puapairoj, A.
Sripa, B.
Tassaneeyakul, W.
Khuntikeo, N.
Wongkham, S.
2011 Journal of Gastroenterology
5 (46), pp. 664-675
3. Anti-inflammatory agents suppress the prostaglandin e2 production and migration ability of Cholangiocarcinoma cell lines Jongthawin, J.
Techasen, A.
Loilome, W.
Yongvanit, P.
Namwat, N.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 47-51
4. Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells Techasen, A.
Loilome, W.
Namwat, N.
Dokduang, H.
Jongthawin, J.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 115-118
5. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma Namwat, N.
Chusorn, P.
Loilome, W.
Techasen, A.
Puetkasichonpasutha, J.
Pairojkul, C.
Khuntikeo, N.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 65-69
6. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development Loilome, W.
Namwat, N.
Techasen, A.
Puapairoj, A.
Pinitsoontorn, C.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 59-64
7. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Yongvanit, P.
Thanan, R.
Pinlaor, S.
Sithithaworn, P.
Loilome, W.
Namwat, N.
Techasen, A.
Dechakhamphu, S.
2012 Parasitology Research
5 (110), pp. 1969-1977
8. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Techasen, A.
Loilome, W.
Namwat, N.
Duenngai, K.
Cha'on, U.
Thanan, R.
Sithithaworn, P.
Miwa, M.
Yongvanit, P.
2012 Parasitology International
1 (61), pp. 140-144
9. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Techasen, A.
Namwat, N.
Loilome, W.
Bungkanjana, P.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2012 Medical Oncology
5 (29), pp. 3083-3091
10. Annexin A1: A new immunohistological marker of cholangiocarcinoma Hongsrichan, N.
Rucksaken, R.
Chamgramol, Y.
Pinlaor, P.
Techasen, A.
Yongvanit, P.
Khuntikeo, N.
Pairojkul, C.
Pinlaor, S.
2013 World Journal of Gastroenterology
16 (19), pp. 2456-2465
11. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Jusakul, A.
Loilome, W.
Namwat, N.
Techasen, A.
Ioannou, G.N.
Yongvanit, P.
2013 Journal of Steroid Biochemistry and Molecular Biology
(138), pp. 368-375
12. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Yothaisong, S.
Dokduang, H.
Techasen, A.
Namwat, N.
Yongvanit, P.
Bhudhisawasdi, V.
Puapairoj, A.
Loilome, W.
2013 Tumor Biology
6 (34), pp. 3637-3648
13. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis Chusorn, P.
Namwat, N.
Loilome, W.
Techasen, A.
Pairojkul, C.
Khuntikeo, N.
Talabnin, C.
Chan-On, W.
Yongvanit, P.
2013 Tumor Biology
3 (34), pp. 1579-1588
14. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Jamnongkan, W.
Techasen, A.
Thanan, R.
Duenngai, K.
Sithithaworn, P.
Mairiang, E.
Loilome, W.
Namwat, N.
Pairojkul, C.
Yongvanit, P.
2013 Tumor Biology
2 (34), pp. 695-704
15. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Dokduang, H.
Juntana, S.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Loilome, W.
2013 Tumor Biology
6 (34), pp. 3519-3528
16. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells Loilome, W.
Bungkanjana, P.
Techasen, A.
Namwat, N.
Yongvanit, P.
Puapairoj, A.
Khuntikeo, N.
2014 Tumor Biology
6 (35), pp. 5357-5367
17. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression Khenjanta, C.
Thanan, R.
Jusakul, A.
Techasen, A.
Jamnongkan, W.
Namwat, N.
Loilome, W.
Pairojkul, C.
Yongvanit, P.
2014 Asian Pacific Journal of Cancer Prevention
23 (15), pp. 10187-10192
18. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma Duangkumpha, K.
Techasen, A.
Loilome, W.
Namwat, N.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 9667-9676
19. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator Loilome, W.
Yongvanit, P.
Chusorn, P.
Techasen, A.
Boonmars, T.
Khuntikeo, N.
Chamadol, N.
Pairojkul, C.
Namwat, N.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
12 (21), pp. 864-872
20. High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014 Asian Pacific Journal of Cancer Prevention
14 (15), pp. 5873-5878
21. Increased EphB2 expression predicts cholangiocarcinoma metastasis Khansaard, W.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Puapairoj, A.
Loilome, W.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 10031-10041
22. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Techasen, A.
Loilome, W.
Namwat, N.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2014 Tumor Biology
9 (35), pp. 8645-8652
23. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J.
Chusorn, P.
Techasen, A.
Loilome, W.
Boonmars, T.
Thanan, R.
Puapairoj, A.
Khuntikeo, N.
Tassaneeyakul, W.
Yongvanit, P.
Namwat, N.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-8064
24. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Dokduang, H.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Pairojkul, C.
Murakami, Y.
Loilome, W.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
10 (21), pp. 767-776
25. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Techasen, A.
Namwat, N.
Loilome, W.
Duangkumpha, K.
Puapairoj, A.
Saya, H.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
9 (21), pp. 703-711
26. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells Thongchot, S.
Loilome, W.
Yongvanit, P.
Dokduang, H.
Thanan, R.
Techasen, A.
Namwat, N.
2015 Asian Pacific Journal of Cancer Prevention
5 (16), pp. 2031-2035
27. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis Thanan, R.
Techasen, A.
Hou, B.
Jamnongkan, W.
Armartmuntree, N.
Yongvanit, P.
2015 Biochemical and Biophysical Research Communications
1 (464), pp. 182-188
28. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wattanawongdon, W.
Hahnvajanawong, C.
Namwat, N.
Kanchanawat, S.
Boonmars, T.
Jearanaikoon, P.
Leelayuwat, C.
Techasen, A.
Seubwai, W.
2015 International Journal of Oncology
1 (47), pp. 398-410
29. Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Boonmars, T.
Pairojkul, C.
Yongvanit, P.
2015 Asian Pacific Journal of Cancer Prevention
7 (16), pp. 3043-3050
30. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Pairojkul, C.
Saya, H.
Yongvanit, P.
2016 Cancer Science
(), pp.
31. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Pairojkul, C.
Saya, H.
Yongvanit, P.
2016 Cancer Science
7 (107), pp. 991-1000
32. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Proungvitaya, T.
Techasen, A.
Limpaiboon, T.
Wongkham, S.
Wongkham, C.
Somintara, O.
Patrakitkomjorn, S.
2016 Tumor Biology
(), pp. 1-9
33. Potential of selenium compounds as new anticancer agents for cholangiocarcinoma Thongchot, S.
Dokduang, H.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
Techasen, A.
Namwat, N.
2016 Anticancer Research
11 (36), pp. 5981-5988
34. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Loilome, W.
Yongvanit, P.
Namwat, N.
Techasen, A.
Khuntikeo, N.
2017 Oncology Letters
2 (13), pp. 639-646
35. Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process Thanee, M.
Techasen, A.
Namwat, N.
Yongvanit, P.
Loilome, W.
2017 Anticancer Research
7 (37), pp. 3591-3597
36. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem Techasen, A.
Loilome, W.
Khuntikeo, N.
Yongvanit, P.
Sithithaworn, P.
2017 International Journal of General Medicine
(10), pp. 227-237
37. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Koonmee, S.
Loilome, W.
2017 Parasitology International
4 (66), pp. 486-493
38. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Techasen, A.
Thongchot, S.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2017 Oncology Letters
5 (14), pp. 5973-5979
39. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool Jamnongkan, W.
Thanan, R.
Techasen, A.
Namwat, N.
Loilome, W.
Intarawichian, P.
Titapun, A.
Yongvanit, P.
2017 Tumor Biology
7 (39), pp. 1-10
40. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Loilome, W.
Yongvanit, P.
Thongchot, S.
Namwat, N.
Sithithaworn, P.
Boonmars, T.
Koonmee, S.
Titapun, A.
Khuntikeo, N.
Chamadol, N.
Techasen, A.
2017 Parasitology International
4 (66), pp. 479-485
41. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Jamnongkan, W.
Thanee, M.
Yongvanit, P.
Loilome, W.
Thanan, R.
Namwat, N.
Techasen, A.
2018 PeerJ
1 (2018), pp.
42. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis Eamudomkarn, C.
Sithithaworn, P.
Sithithaworn, J.
Kaewkes, S.
Techasen, A.
Loilome,
Yongvanit, P.
Saichua, P.
Itoh, M.
2018 PLoS ONE
7 (13), pp.
43. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018 FEBS Open Bio
4 (8), pp. 513-522
44. Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth Dokduang, H.
Yothaisong, S.
Techasen, A.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Loilome,
2018 Oncology Letters
2 (16), pp. 1627-1633
45. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Thongchot, S.
Loilome,
Techasen, A.
Ungarreevittaya, P.
Khuntikeo, N.
Yongvanit, P.
2018 PLoS ONE
6 (13), pp.
46. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Loilome, W.
Techasen, A.
Thanee, M.
Titapun, A.
Yongvanit, P.
Namwat, N.
2018 OncoTargets and Therapy
(11), pp. 395-408
47. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Armartmuntree, N.
Techasen, A.
Yongvanit, P.
Loilome, W.
Pairojkul, C.
Sakonsinsiri, C.
Pinlaor, S.
Thanan, R.
2018 Redox Biology
(14), pp. 637-644
48. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine Techasen, A.
Thongchot, S.
Loilome, W.
Thanan, R.
Yongvanit, P.
Titapun, A.
Khuntikeo, N.
Namwat, N.
2018 Oncology Letters
1 (15), pp. 347-353
49. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway Thanee, M.
Techasen, A.
Klanrit,
Titapun, A.
Loilome,
2018 OncoTargets and Therapy
(11), pp. 7019-7029
50. Accuracy of urine and serum assays for the diagnosis of strongyloidiasis by three enzyme-linked immunosorbent assay protocols Eamudomkarn, C.
Techasen, A.
Sithithaworn, J.
Itoh, M.
Sithithaworn, P.
2019 American Journal of Tropical Medicine and Hygiene
1 (100), pp. 127-129
51. Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Duenngai, K.
Kiatsopit, N.
Kopolrat, K.
Techasen, A.
Sithithaworn, J.
Khuntikeo, N.
Loilome,
Yongvanit, P.
Sithithaworn, P.
2019 PLoS Neglected Tropical Diseases
2 (13), pp.
52. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019 Journal of Proteome Research
9 (18), pp. 3305-3316
53. Discovery of serotransferrin glycoforms: Novel markers for diagnosis of liver periductal fibrosis and prediction of cholangiocarcinoma Jamnongkan, W.
Techasen, A.
Loilome,
Sithithaworn, P.
Khuntikeo, N.
Pairojkul, C.
Chamadol, N.
Thanan, R.
Yongvanit, P.
2019 Biomolecules
10 (9), pp.
54. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Promraksa, B.
Phetcharaburanin, J.
Techasen, A.
Boonsiri, P.
Loilome,
2019 PLoS ONE
5 (14), pp.
55. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG Thanan, R.
Eamudomkarn, C.
Techasen, A.
Sithithaworn, J.
Loilome,
Chamadol, N.
Pinlaor, S.
Jumnainsong, A.
Yongvanit, P.
Khuntikeo, N.
Sithithaworn, P.
2019 Acta Tropica
(189), pp. 124-128
56. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Klanrit,
Phetcharaburanin, J.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Loilome,
2019 PLoS ONE
9 (14), pp.
57. Roles of zinc finger protein 423 in proliferation and invasion of cholangiocarcinoma through oxidative stress Armartmuntree, N.
Techasen, A.
Sakonsinsiri, C.
Pinlaor, S.
Ungarreevittaya, P.
Khuntikeo, N.
Thanan, R.
2019 Biomolecules
7 (9), pp.
58. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019 PLoS ONE
8 (14), pp.
59. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Jamnongkan, W.
Techasen, A.
Phetcharaburanin, J.
Sithithaworn, P.
Khuntikeo, N.
Mukdasai, S.
Sayasone, S.
Loilome, W.
Ngeontae, W.
2020 Talanta
(209), pp.
60. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Thongchot, S.
Thanee, M.
Loilome, W.
Techasen, A.
Titapun, A.
Yongvanit, P.
Namwat, N.
2020 Journal of Traditional and Complementary Medicine
(), pp.
61. Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression Thanan, R.
Sakonsinsiri, C.
Armartmuntree, N.
Techasen, A.
Klanrit, P.
Lert-Itthiporn, W.
Pinlaor, S.
Pairojkul, C.
2020 International Journal of Molecular Sciences
5 (21), pp.

Title Authors Year Journal title
1. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Techasen, A
Loilome, W
Namwat, N
Takahashi, E
Sugihara, E
Puapairoj, A
Miwa, M
Saya, H
Yongvanit, P
2010 Cancer science
3 (101), pp. 658-65
2. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. Namwat, N
Puetkasichonpasutha, J
Loilome, W
Yongvanit, P
Techasen, A
Puapairoj, A
Sripa, B
Tassaneeyakul, W
Khuntikeo, N
Wongkham, S
2011 Journal of gastroenterology
5 (46), pp. 664-75
3. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Techasen, A
Namwat, N
Loilome, W
Bungkanjana, P
Khuntikeo, N
Puapairoj, A
Jearanaikoon, P
Saya, H
Yongvanit, P
2012 Medical oncology (Northwood, London, England)
5 (29), pp. 3083-91
4. Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. Jongthawin, J
Techasen, A
Loilome, W
Yongvanit, P
Namwat, N
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 47-51
5. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. Loilome, W
Kadsanit, S
Namwat, N
Techasen, A
Puapairoj, A
Dechakhamphu, A
Pinitsoontorn, C
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 59-64
6. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. Techasen, A
Loilome, W
Namwat, N
Dokduang, H
Jongthawin, J
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 115-8
7. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma. Namwat, N
Chusorn, P
Loilome, W
Techasen, A
Puetkasichonpasutha, J
Pairojkul, C
Khuntikeo, N
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 65-9
8. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. Techasen, A
Loilome, W
Namwat, N
Duenngai, K
Cha'on, U
Thanan, R
Sithithaworn, P
Miwa, M
Yongvanit, P
2012 Parasitology international
1 (61), pp. 140-4
9. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. Yongvanit, P
Thanan, R
Pinlaor, S
Sithithaworn, P
Loilome, W
Namwat, N
Techasen, A
Dechakhamphu, S
2012 Parasitology research
5 (110), pp. 1969-77
10. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. Jusakul, A
Loilome, W
Namwat, N
Techasen, A
Kuver, R
Ioannou, GN
Savard, C
Haigh, WG
Yongvanit, P
2013 The Journal of steroid biochemistry and molecular biology
(138), pp. 368-75
11. Annexin A1: A new immunohistological marker of cholangiocarcinoma. Hongsrichan, N
Rucksaken, R
Chamgramol, Y
Pinlaor, P
Techasen, A
Yongvanit, P
Khuntikeo, N
Pairojkul, C
Pinlaor, S
2013 World journal of gastroenterology : WJG
16 (19), pp. 2456-65
12. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong, S
Dokduang, H
Techasen, A
Namwat, N
Yongvanit, P
Bhudhisawasdi, V
Puapairoj, A
Riggins, GJ
Loilome, W
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (34), pp. 3637-48
13. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Chusorn, P
Namwat, N
Loilome, W
Techasen, A
Pairojkul, C
Khuntikeo, N
Dechakhamphu, A
Talabnin, C
Chan-On, W
Ong, CK
Teh, BT
Yongvanit, P
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (34), pp. 1579-88
14. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Jamnongkan, W
Techasen, A
Thanan, R
Duenngai, K
Sithithaworn, P
Mairiang, E
Loilome, W
Namwat, N
Pairojkul, C
Yongvanit, P
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2 (34), pp. 695-704
15. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. Dokduang, H
Juntana, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Riggins, GJ
Loilome, W
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (34), pp. 3519-28
16. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-64
17. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Thongchot, S
Yongvanit, P
Loilome, W
Seubwai, W
Phunicom, K
Tassaneeyakul, W
Pairojkul, C
Promkotra, W
Techasen, A
Namwat, N
2014 Asian Pacific journal of cancer prevention : APJCP
14 (15), pp. 5873-8
18. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Techasen, A
Loilome, W
Namwat, N
Khuntikeo, N
Puapairoj, A
Jearanaikoon, P
Saya, H
Yongvanit, P
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
9 (35), pp. 8645-52
19. Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. Miwa, M
Honjo, S
You, G
Tanaka, M
Uchida, K
Srivatanakul, P
Khuhaprema, T
Loilome, W
Techasen, A
Wongkham, C
Limpaiboon, T
Yongvanit, P
Wongkham, S
2014 World journal of gastrointestinal pathophysiology
4 (5), pp. 570-8
20. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Khenjanta, C
Thanan, R
Jusakul, A
Techasen, A
Jamnongkan, W
Namwat, N
Loilome, W
Pairojkul, C
Yongvanit, P
2014 Asian Pacific journal of cancer prevention : APJCP
23 (15), pp. 10187-92
21. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. Silakit, R
Loilome, W
Yongvanit, P
Chusorn, P
Techasen, A
Boonmars, T
Khuntikeo, N
Chamadol, N
Pairojkul, C
Namwat, N
2014 Journal of hepato-biliary-pancreatic sciences
12 (21), pp. 864-72
22. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. Dokduang, H
Techasen, A
Namwat, N
Khuntikeo, N
Pairojkul, C
Murakami, Y
Loilome, W
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
10 (21), pp. 767-76
23. Increased EphB2 expression predicts cholangiocarcinoma metastasis. Khansaard, W
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Loilome, W
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 10031-41
24. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. Duangkumpha, K
Techasen, A
Loilome, W
Namwat, N
Thanan, R
Khuntikeo, N
Yongvanit, P
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 9667-76
25. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. Techasen, A
Namwat, N
Loilome, W
Duangkumpha, K
Puapairoj, A
Saya, H
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
9 (21), pp. 703-11
26. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Loilome, W
Bungkanjana, P
Techasen, A
Namwat, N
Yongvanit, P
Puapairoj, A
Khuntikeo, N
Riggins, GJ
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (35), pp. 5357-67
27. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. Thanee, M
Loilome, W
Techasen, A
Namwat, N
Boonmars, T
Pairojkul, C
Yongvanit, P
2015 Asian Pacific journal of cancer prevention : APJCP
7 (16), pp. 3043-50
28. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. Thongchot, S
Loilome, W
Yongvanit, P
Dokduang, H
Thanan, R
Techasen, A
Namwat, N
2015 Asian Pacific journal of cancer prevention : APJCP
5 (16), pp. 2031-5
29. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. Nutthasirikul, N
Hahnvajanawong, C
Techasen, A
Limpaiboon, T
Leelayuwat, C
Chau-In, S
Jearanaikoon, P
2015 International journal of oncology
(), pp.
30. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. Worasith, C
Kamamia, C
Yakovleva, A
Duenngai, K
Wangboon, C
Sithithaworn, J
Watwiengkam, N
Namwat, N
Techasen, A
Loilome, W
Yongvanit, P
Loukas, A
Sithithaworn, P
Bethony, JM
2015 PLoS neglected tropical diseases
10 (9), pp. e0004157
31. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis. Thanan, R
Techasen, A
Hou, B
Jamnongkan, W
Armartmuntree, N
Yongvanit, P
Murata, M
2015 Biochemical and biophysical research communications
1 (464), pp. 182-8
32. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. Wattanawongdon, W
Hahnvajanawong, C
Namwat, N
Kanchanawat, S
Boonmars, T
Jearanaikoon, P
Leelayuwat, C
Techasen, A
Seubwai, W
2015 International journal of oncology
1 (47), pp. 398-410
33. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. Chua-On, D
Proungvitaya, T
Techasen, A
Limpaiboon, T
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sungkhamanon, S
Proungvitaya, S
2016 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (37), pp. 13659-13667
34. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. Thanee, M
Loilome, W
Techasen, A
Sugihara, E
Okazaki, S
Abe, S
Ueda, S
Masuko, T
Namwat, N
Khuntikeo, N
Titapun, A
Pairojkul, C
Saya, H
Yongvanit, P
2016 Cancer science
7 (107), pp. 991-1000
35. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. Dai, X
Thongchot, S
Dokduang, H
Loilome, W
Khuntikeo, N
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Techasen, A
Namwat, N
2016 Anticancer research
11 (36), pp. 5981-5988
36. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. Silakit, R
Loilome, W
Yongvanit, P
Thongchot, S
Sithithaworn, P
Boonmars, T
Koonmee, S
Titapun, A
Khuntikeo, N
Chamadol, N
Techasen, A
Namwat, N
2017 Parasitology international
4 (66), pp. 479-485
37. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Suksawat, M
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Koonmee, S
Loilome, W
2017 Parasitology international
4 (66), pp. 486-493
38. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. Loilome, W
Kadsanit, S
Muisook, K
Yongvanit, P
Namwat, N
Techasen, A
Puapairoj, A
Khuntikeo, N
Phonjit, P
2017 Oncology letters
2 (13), pp. 639-646
39. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Padthaisong, S
Thanee, M
Techasen, A
Namwat, N
Yongvanit, P
Liwatthakun, A
Hankla, K
Sangkhamanon, S
Loilome, W
2017 Anticancer research
7 (37), pp. 3591-3597
40. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. Jamnongkan, W
Thanan, R
Techasen, A
Namwat, N
Loilome, W
Intarawichian, P
Titapun, A
Yongvanit, P
2017 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
7 (39), pp. 1010428317717655
41. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem. Hughes, T
O'Connor, T
Techasen, A
Namwat, N
Loilome, W
Andrews, RH
Khuntikeo, N
Yongvanit, P
Sithithaworn, P
Taylor-Robinson, SD
2017 International journal of general medicine
(10), pp. 227-237
42. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Armartmuntree, N
Murata, M
Techasen, A
Yongvanit, P
Loilome, W
Namwat, N
Pairojkul, C
Sakonsinsiri, C
Pinlaor, S
Thanan, R
2017 Redox biology
(14), pp. 637-644
43. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. Khophai, S
Thanee, M
Techasen, A
Namwat, N
Klanrit, P
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Loilome, W
2018 OncoTargets and therapy
(11), pp. 7019-7029
44. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. Jamnongkan, W
Thanee, M
Yongvanit, P
Loilome, W
Thanan, R
Kimawaha, P
Boonmars, T
Silakit, R
Namwat, N
Techasen, A
2018 PeerJ
(6), pp. e4281
45. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018 Oncology letters
1 (15), pp. 347-353
46. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. Daya, M
Loilome, W
Techasen, A
Thanee, M
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Namwat, N
2018 OncoTargets and therapy
(11), pp. 395-408
47. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. Suksawat, M
Techasen, A
Namwat, N
Boonsong, T
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Loilome, W
2018 FEBS open bio
4 (8), pp. 513-522
48. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. Silakit, R
Kitirat, Y
Thongchot, S
Loilome, W
Techasen, A
Ungarreevittaya, P
Khuntikeo, N
Yongvanit, P
Yang, JH
Kim, NH
Yook, JI
Namwat, N
2018 PloS one
6 (13), pp. e0199827
49. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. Eamudomkarn, C
Sithithaworn, P
Kamamia, C
Yakovleva, A
Sithithaworn, J
Kaewkes, S
Techasen, A
Loilome, W
Yongvanit, P
Wangboon, C
Saichua, P
Itoh, M
M Bethony, J
2018 PloS one
7 (13), pp. e0192598
50. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Padthaisong, S
Dokduang, H
Yothaisong, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Sangkhamanon, S
Loilome, W
2018 Oncology letters
2 (16), pp. 1627-1633
51. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. Wangboon, C
Worasith, C
Thanan, R
Eamudomkarn, C
Techasen, A
Sithithaworn, J
Loilome, W
Chamadol, N
Pinlaor, S
Jumnainsong, A
Yongvanit, P
Khuntikeo, N
Bethony, JM
Sithithaworn, P
2018 Acta tropica
(189), pp. 124-128
52. Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols. Ruantip, S
Eamudomkarn, C
Techasen, A
Wangboon, C
Sithithaworn, J
Bethony, JM
Itoh, M
Sithithaworn, P
2019 The American journal of tropical medicine and hygiene
1 (100), pp. 127-129
53. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. Promraksa, B
Phetcharaburanin, J
Namwat, N
Techasen, A
Boonsiri, P
Loilome, W
2019 PloS one
5 (14), pp. e0216721
54. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. Worasith, C
Wangboon, C
Duenngai, K
Kiatsopit, N
Kopolrat, K
Techasen, A
Sithithaworn, J
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Carlton, EJ
Sithithaworn, P
2019 PLoS neglected tropical diseases
2 (13), pp. e0007186
55. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. Suksawat, M
Klanrit, P
Phetcharaburanin, J
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Techasen, A
Loilome, W
2019 PloS one
9 (14), pp. e0222140
56. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019 Journal of proteome research
9 (18), pp. 3305-3316
57. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019 PloS one
8 (14), pp. e0221024
58. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. Taron, W
Jamnongkan, W
Techasen, A
Phetcharaburanin, J
Namwat, N
Sithithaworn, P
Khuntikeo, N
Mukdasai, S
Sayasone, S
Loilome, W
Ngeontae, W
2020 Talanta
(209), pp. 120592
59. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. Kimawaha, P
Jusakul, A
Junsawang, P
Loilome, W
Khuntikeo, N
Techasen, A
2020 Journal of gastrointestinal oncology
2 (11), pp. 304-318

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Eri Takahashi
Eiji Sugihara
Anucha Puapairoj
Masanao Miwa
Hideyuki Saya
Puangrat Yongvanit
2010 CANCER SCIENCE
3.0 (101.0), pp. 658.0-665.0
74 0 0 0 0 0 74
2. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011 JOURNAL OF GASTROENTEROLOGY
5.0 (46.0), pp. 664.0-675.0
53 0 0 0 0 0 53
3. Anti-inflammatory Agents Suppress the Prostaglandin E-2 Production and Migration Ability of Cholangiocarcinoma Cell Lines Jurairat Jongthawin
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 47.0-51.0
17 0 0 0 0 0 17
4. Cytokines Released from Activated Human Macrophages Induce Epithelial Mesenchymal Transition Markers of Cholangiocarcinoma Cells Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Hasaya Dokduang
Jurairat Jongthawin
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 115.0-118.0
51 0 0 0 0 0 51
5. Expression Profiles of Oncomir miR-21 and Tumor Suppressor let-7a in the Progression of Opisthorchiasis-Associated Cholangiocarcinoma N. Namwat
P. Chusorn
W. Loilome
A. Techasen
J. Puetkasichonpasutha
C. Pairojkul
N. Khuntikeo
P. Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 65.0-69.0
25 0 0 0 0 0 25
6. Impaired Antioxidant Enzyme Activity and Increased DNA Repair Enzyme Expression in Hamster Liver Tissues Related to Cholangiocarcinoma Development Watcharin Loilome
Sasithorn Kadsanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Ananya Dechakhamphu
Chadamas Pinitsoontorn
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 59.0-64.0
3 0 0 0 0 0 3
7. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Puangrat Yongvanit
Raynoo Thanan
Somchai Pinlaor
Paiboon Sithithaworn
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Somkid Dechakhamphu
2012 PARASITOLOGY RESEARCH
5.0 (110.0), pp. 1969.0-1977.0
16 0 0 0 0 0 16
8. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Kunyarat Duenngai
Ubon Cha'on
Raynoo Thanan
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 140.0-144.0
12 0 0 0 0 0 12
9. Tumor Necrosis Factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma A. Techasen
N. Namwat
W. Loilome
2012 FEBS JOURNAL
(279.0), pp. 169.0-170.0
0 0 0 0 0 0 0
10. Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Pornpan Bungkanjana
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2012 MEDICAL ONCOLOGY
5.0 (29.0), pp. 3083.0-3091.0
74 0 0 0 0 0 74
11. Annexin A1: A new immunohistological marker of cholangiocarcinoma Nuttanan Hongsrichan
Rucksak Rucksaken
Yaovalux Chamgramol
Porntip Pinlaor
Anchalee Techasen
Puangrat Yongvanit
Narong Khuntikeo
Chawalit Pairojkul
Somchai Pinlaor
2013 WORLD JOURNAL OF GASTROENTEROLOGY
16.0 (19.0), pp. 2456.0-2465.0
22 0 0 0 0 0 22
12. Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Apinya Jusakul
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Rahul Kuver
George N. Ioannou
Christopher Savard
W. Geoffrey Haigh
Puangrat Yongvanit
2013 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
(138.0), pp. 368.0-375.0
14 0 0 0 0 0 14
13. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Supak Yothaisong
Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Gregory J. Riggins
Watcharin Loilome
2013 TUMOR BIOLOGY
6.0 (34.0), pp. 3637.0-3648.0
73 0 0 0 0 0 73
14. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
A. Dechakhamphu
C. Talabnin
W. Chan-On
C. K. Ong
B. T. Teh
P. Yongvanit
2013 TUMOR BIOLOGY
3.0 (34.0), pp. 1579.0-1588.0
65 0 0 0 0 0 65
15. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Wassana Jamnongkan
Anchalee Techasen
Raynoo Thanan
Kunyarat Duenngai
Paiboon Sithithaworn
Eimorn Mairiang
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Puangrat Yongvanit
2013 TUMOR BIOLOGY
2.0 (34.0), pp. 695.0-704.0
23 0 0 0 0 0 23
16. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Hasaya Dokduang
Sirinun Juntana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Gregory J. Riggins
Watcharin Loilome
2013 TUMOR BIOLOGY
6.0 (34.0), pp. 3519.0-3528.0
36 0 0 0 0 0 36
17. The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma Jurairat Jongthawin
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Chavalit Pairojkul
Narong Khuntikeo
Nisana Namwat
2013 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(28.0), pp. 425.0-425.0
0 0 0 0 0 0 0
18. Activated macrophages promote Wnt/beta-catenin signaling in cholangiocarcinoma cells Watcharin Loilome
Pornpan Bungkanjana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Anucha Puapairoj
Narong Khuntikeo
Gregory J. Riggins
2014 TUMOR BIOLOGY
6.0 (35.0), pp. 5357.0-5367.0
60 0 0 0 0 0 60
19. Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
23.0 (15.0), pp. 10187.0-10192.0
12 0 0 0 0 0 12
20. BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma Kassaporn Duangkumpha
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Raynoo Thanan
Narong Khuntikeo
Puangrat Yongvanit
2014 TUMOR BIOLOGY
10.0 (35.0), pp. 9667.0-9676.0
49 0 0 0 0 0 49
21. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Porncheera Chusorn
Anchalee Techasen
Thidarut Boonmars
Narong Khuntikeo
Nittaya Chamadol
Chawalit Pairojkul
Nisana Namwat
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
12.0 (21.0), pp. 864.0-872.0
66 0 0 0 0 0 66
22. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
14.0 (15.0), pp. 5873.0-5878.0
37 0 0 0 0 0 37
23. Increased EphB2 expression predicts cholangiocarcinoma metastasis Walaiporn Khansaard
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Watcharin Loilome
2014 TUMOR BIOLOGY
10.0 (35.0), pp. 10031.0-10041.0
26 0 0 0 0 0 26
24. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2014 TUMOR BIOLOGY
9.0 (35.0), pp. 8645.0-8652.0
43 0 0 0 0 0 43
25. PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jurairat Jongthawin
Porncheera Chusorn
Anchalee Techasen
Watcharin Loilome
Thidarut Boonmars
Raynoo Thanan
Anucha Puapairoj
Narong Khuntikeo
Wichittra Tassaneeyakul
Puangrat Yongvanit
Nisana Namwat
2014 TUMOR BIOLOGY
8.0 (35.0), pp. 8051.0-8064.0
10 0 0 0 0 0 10
26. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Chawalit Pairojkul
Yoshinori Murakami
Watcharin Loilome
Puangrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
10.0 (21.0), pp. 767.0-776.0
52 0 0 0 0 0 52
27. Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment W. Loilome
H. Dokduang
S. Yothaisong
P. Bungkanjana
S. Juntana
A. Techasen
N. Namwat
P. Yongvanit
N. Khuntikeo
A. Puapairoj
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S210-S210
0 0 0 0 0 0 0
28. TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
B. Tean Teh
I. Lee
P. Yongvanit
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S63-S64
0 0 0 0 0 0 0
29. Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Kassaporn Duangkumpha
Anucha Puapairoj
Hideyuki Saya
Puangrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
9.0 (21.0), pp. 703.0-711.0
44 0 0 0 0 0 44
30. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine Chanika Worasith
Christine Kamamia
Anna Yakovleva
Kunyarat Duenngai
Chompunoot Wangboon
Jiraporn Sithithaworn
Nattaya Watwiengkam
Nisana Namwat
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Alex Loukas
Paiboon Sithithaworn
Jeffrey M. Bethony
2015 PLoS Neglected Tropical Diseases
10.0 (9.0), pp.
35 2 0 0 0 0 37
31. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis Raynoo Thanan
Anchalee Techasen
Bo Hou
Wassana Jamnongkan
Napat Armartmuntree
Puangrat Yongvanit
Mariko Murata
2015 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
1.0 (464.0), pp. 182.0-188.0
25 0 0 0 0 0 25
32. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wareeporn Wattanawongdon
Chariya Hahnvajanawong
Nisana Namwat
Sirimas Kanchanawat
Thidarut Boonmars
Patcharee Jearanaikoon
Chanwit Leelayuwat
Anchalee Techasen
Wunchana Seubwai
2015 INTERNATIONAL JOURNAL OF ONCOLOGY
1.0 (47.0), pp. 398.0-410.0
34 0 0 0 0 0 34
33. Targeting the Delta 133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells Nichapavee Nutthasirikul
Chariya Hahnvajanawong
Anchalee Techasen
Temduang Limpaiboon
Chanvit Leelayuwat
Siri Chau-In
Patcharee Jearanaikoon
2015 INTERNATIONAL JOURNAL OF ONCOLOGY
6.0 (47.0), pp. 2153.0-2164.0
12 0 0 0 0 0 12
34. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Eiji Sugihara
Shogo Okazaki
Shinya Abe
Shiho Ueda
Takashi Masuko
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Chawalit Pairojkul
Hideyuki Saya
Puangrat Yongvanit
2016 CANCER SCIENCE
7.0 (107.0), pp. 991.0-1000.0
36 0 0 0 0 0 36
35. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma Daraporn Chua-on
Tanakorn Proungvitaya
Anchalee Techasen
Temduang Limpaiboon
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sungkhamanon
Siriporn Proungvitaya
2016 TUMOR BIOLOGY
10.0 (37.0), pp. 13659.0-13667.0
17 0 0 0 0 0 17
36. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Hasaya Dokduang
Watcharin Loilome
Narong Khuntikeo
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Anchalee Techasen
Nisana Namwat
2016 ANTICANCER RESEARCH
11.0 (36.0), pp. 5981.0-5988.0
12 0 0 0 0 0 12
37. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Watcharin Loilome
Sasithorn Kadsanit
Kanha Muisook
Puangrat Yongvanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Narong Khuntikeo
Pichai Phonjit
2017 ONCOLOGY LETTERS
2.0 (13.0), pp. 639.0-646.0
0 0 0 0 0 0 0
38. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017 ANTICANCER RESEARCH
7.0 (37.0), pp. 3591.0-3597.0
14 0 0 0 0 0 14
39. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem Thomas Hughes
Thomas O'Connor
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Ross H. Andrews-
Narong Khuntikeo
Puangrat Yongvanit
Paiboon Sithithaworn
Simon D. Taylor-Robinson
2017 INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(10.0), pp. 227.0-237.0
31 0 0 0 0 0 31
40. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Manida Suksawat
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Supinda Koonmee
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 486.0-493.0
10 0 0 0 0 0 10
41. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017 ONCOLOGY LETTERS
5.0 (14.0), pp. 5973.0-5979.0
4 0 0 0 0 0 4
42. Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool Wassana Jamnongkan
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Piyapharom Intarawichian
Attapol Titapun
Puangrat Yongvanit
2017 TUMOR BIOLOGY
7.0 (39.0), pp.
12 0 0 0 0 0 12
43. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Suyanee Thongchot
Paiboon Sithithaworn
Thidarut Boonmars
Supinda Koonmee
Attapol Titapun
Narong Khuntikeo
Nittaya Chamadol
Anchalee Techasen
Nisana Namwat
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 479.0-485.0
26 0 0 0 0 0 26
44. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Rayno Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
Anchalee Techasen
2018 PEERJ
(6.0), pp.
4 0 0 0 0 0 4
45. CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Nisana Namwat
Attapon Titapun
Narong Khuntikeo
Shogo Okazaki
Eiji Sugihara
Hideyuki Saya
Puangrat Yongvanit
2018 CANCER SCIENCE
(109.0), pp. 37.0-37.0
0 0 0 0 0 0 0
46. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis Chatanun Eamudomkarn
Paiboon Sithithaworn
Christine Kamamia
Anna Yakovleva
Jiraporn Sithithaworn
Sasithorn Kaewkes
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Chompunoot Wangboon
Prasert Saichua
Makoto Itoh
Jeffrey M. Bethony
2018 PLOS ONE
7.0 (13.0), pp.
6 0 0 0 0 0 6
47. Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis Anchalee Techasen
Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
2018 CANCER SCIENCE
(109.0), pp. 721.0-721.0
0 0 0 0 0 0 0
48. Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development Sasikamon Korphai
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 194.0-194.0
0 0 0 0 0 0 0
49. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy Manida Suksawat
Anchalee Techasen
Nisana Namwat
Thianrut Boonsong
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Watcharin Loilome
2018 FEBS OPEN BIO
4.0 (8.0), pp. 513.0-522.0
3 0 0 0 0 0 3
50. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 746.0-746.0
0 0 0 0 0 0 0
51. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 ONCOLOGY LETTERS
2.0 (16.0), pp. 1627.0-1633.0
3 0 0 0 0 0 3
52. Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018 CANCER SCIENCE
(109.0), pp. 1286.0-1286.0
0 0 0 0 0 0 0
53. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 745.0-745.0
0 0 0 0 0 0 0
54. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Runglawan Silakit
Yingpinyapat Kitirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Piti Ungarreevittaya
Narong Khuntikeo
Puangrat Yongvanit
Ji Hye Yang
Nam Hee Kim
Jong In Yook
Nisana Namwat
2018 PLOS ONE
6.0 (13.0), pp.
4 0 0 0 0 0 4
55. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Minerva Daya
Watcharin Loilome
Anchalee Techasen
Malinee Thanee
Prakasit Sa-Ngiamwibool
Attapol Titapun
Puangrat Yongvanit
Nisana Namwat
2018 ONCOTARGETS AND THERAPY
(11.0), pp. 395.0-408.0
11 0 0 0 0 0 11
56. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018 REDOX BIOLOGY
(14.0), pp. 637.0-644.0
53 0 0 0 0 0 53
57. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018 ONCOLOGY LETTERS
1.0 (15.0), pp. 347.0-353.0
8 0 0 0 0 0 8
58. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018 CANCER SCIENCE
(109.0), pp. 956.0-956.0
0 0 0 0 0 0 0
59. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway Sasikamon Khophai
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Poramate Klanrit
Attapol Titapun
Apiwat Jarearnrat
Prakasit Sa-Ngiamwibool
Watcharin Loilome
2018 ONCOTARGETS AND THERAPY
(11.0), pp. 7019.0-7029.0
2 0 0 0 0 0 2
60. ZNF423 expression in relation to oxidative stress-induced CCA progression Timpika Chaiprasert
Napat Armartmuntree
Chadamas Sakonsinsiri
Somchai Pinlaor
Anchalee Techasen
Raynoo Thanan
2018 CANCER SCIENCE
(109.0), pp. 1285.0-1285.0
0 0 0 0 0 0 0
61. Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols Sirowan Ruantip
Chatanun Eamudomkarn
Anchalee Techasen
Chompunoot Wangboon
Jiraporn Sithithaworn
Jeffrey M. Bethony
Makoto Itoh
Paiboon Sithithaworn
2019 AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
1.0 (100.0), pp. 127.0-129.0
4 0 0 0 0 0 4
62. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Chanika Worasith
Chompunoot Wangboon
Kunyarat Duenngai
Nadda Kiatsopit
Kulthida Kopolrat
Anchalee Techasen
Jiraporn Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Nisana Namwat
Puangrat Yongvanit
Elizabeth J. Carlton
Paiboon Sithithaworn
2019 PLOS NEGLECTED TROPICAL DISEASES
2.0 (13.0), pp.
0 0 0 0 0 0 0
63. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019 JOURNAL OF PROTEOME RESEARCH
9.0 (18.0), pp. 3305.0-3316.0
1 0 0 0 0 0 1
64. Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma Wassana Jamnongkan
Carlito B. Lebrilla
Mariana Barboza
Anchalee Techasen
Watcharin Loilome
Paiboon Sithithaworn
Narong Khuntikeo
Chawalit Pairojkul
Nittaya Chamadol
Raynoo Thanan
Puangrat Yongvanit
2019 BIOMOLECULES
10.0 (9.0), pp.
1 0 0 0 0 0 1
65. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Bundit Promraksa
Jutarop Phetcharaburanin
Nisana Namwat
Anchalee Techasen
Patcharee Boonsiri
Watcharin Loilome
2019 PLOS ONE
5.0 (14.0), pp.
0 0 0 0 0 0 0
66. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG Chompunoot Wangboon
Chanika Worasith
Raynoo Thanan
Chatanun Eamudomkarn
Anchalee Techasen
Jiraporn Sithithaworn
Watcharin Loilome
Nittaya Chamadol
Somchai Pinlaor
Amonrat Jumnainsong
Puangrat Yongvanit
Narong Khuntikeo
Jeffrey M. Bethony
Paiboon Sithithaworn
2019 ACTA TROPICA
(189.0), pp. 124.0-128.0
2 0 0 0 0 0 2
67. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress Timpika Chaiprasert
Napat Armartmuntree
Anchalee Techasen
Chadamas Sakonsinsiri
Somchai Pinlaor
Piti Ungarreevittaya
Narong Khuntikeo
Nisana Namwat
Raynoo Thanan
2019 BIOMOLECULES
7.0 (9.0), pp.
0 0 0 0 0 0 0
68. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019 PLOS ONE
8.0 (14.0), pp.
0 0 0 0 0 0 0
69. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Wichit Taron
Wassana Jamnongkan
Anchalee Techasen
Jutarop Phetcharaburanin
Nisana Namwat
Paiboon Sithithaworn
Narong Khuntikeo
Siriboon Mukdasai
Somphou Sayasone
Watcharin Loilome
Wittaya Ngeontae
2020 TALANTA
(209.0), pp.
0 0 0 0 0 0 0
70. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression Raynoo Thanan
Waleeporn Kaewlert
Chadamas Sakonsinsiri
Timpika Chaiprasert
Napat Armartmuntree
Duangkamon Muengsaen
Anchalee Techasen
Poramate Klanrit
Worachart Lert-itthiporn
Somchai Pinlaor
Chawalit Pairojkul
2020 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
5.0 (21.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title
1. Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model Hasaya Dokduang
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Chawalit Pairojkul
Narong Khuntikeo
Yoshinori Murakami
Puangrat Yongvanit
2013 Srinagarind Medical Journal
(28 No 4), pp. 195
2. Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression Yingpinyapat Kittirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 133-135
3. Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 138-140
4. Gene Silencing of Translationally Controlled Tumor Protein (TCTP) Nattaporn Phanthaphol
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 136-137

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ
1. แบบแผนเปบทีโดมิกส์ในปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อัญชลี เตชะเสน
ดร. สิทธิรักษ์ รอยตระกูล
รศ.ดร.นพ. ณรงค์ ขันตีแก้ว
รศ.ดร. นิษณา นามวาท
ศ.ดร. ไพบูลย์ สิทธิถาวร
ศ.ดร. พวงรัตน์ ยงวณิชย์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
2. แบบแผนโปรทิโอมิกส์ในซีรัมของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง ศ.ดร. พวงรัตน์ ยงวณิชย์
อ.ดร. อัญชลี เตชะเสน
ดร. สิทธิรักษ์ รอยตระกูล
รศ.ดร.นพ. ณรงค์ ขันตีแก้ว
รศ.ดร. นิษณา นามวาท
ศ.ดร. ไพบูลย์ สิทธิถาวร
รศ.ดร. วัชรินทร์ ลอยลม
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
3. แบบแผนไมโครอาร์เอ็นเอในซีรัมและปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยงของโรคมะเร็งท่อน้ำดี รศ.ดร. นิษณา นามวาท
ศ.ดร. ไพบูลย์ สิทธิถาวร
นายชวลิต ไพโรจน์กุล
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อัญชลี เตชะเสน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
4. กลไกการเปลี่ยนแปลงรูปร่างของเซลล์จากเยื่อบุผิวเป็นมีเซนไคม์ในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา อ.ดร. อัญชลี เตชะเสน
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. วัชรินทร์ ลอยลม
รศ.ดร. นิษณา นามวาท
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ผศ.ดร. เรณู ทานันท์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
5. การควบคุมวิถีออโตฟาจีในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา รศ.ดร. นิษณา นามวาท
รศ.ดร. วัชรินทร์ ลอยลม
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ศ.ดร. พวงรัตน์ ยงวณิชย์
ผศ.ดร. เรณู ทานันท์
อ.ดร. อัญชลี เตชะเสน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
6. การประเมินลายพิมพ์อินฟราเรดสเปคตรัมที่สัมพันธ์กับ การเกิดไฟโบรซิสเพื่อใช้เป็นตัวบ่งชี้แนวใหม่ในการติดตามการดำเนินของโรคมะเร็งท่อน้ำดี ผศ.ดร. อมรรัตน์ จำเนียรทรง
รศ.ดร. พัชรี เจียรนัยกูร
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
รศ.ดร.นพ. ณรงค์ ขันตีแก้ว
ผศ.ดร. พัชราภรณ์ ทิพยวัฒน์
นางนิชาดา เจียรนัยกูร
อ.ดร. อัญชลี เตชะเสน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
7. บทบาทของยีนก่อมะเร็งท่อน้ำดีในสภาวะความเครียดออกซิเดชันที่สัมพันธ์กับกระบวนการเหนือพันธุกรรมเพื่อการป้องกันและรักษาโรค ผศ.ดร. เรณู ทานันท์
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. วัชรินทร์ ลอยลม
ศ.ดร. สมชาย ปิ่นละออ
อ.ดร. อัญชลี เตชะเสน
รศ.ดร. นิษณา นามวาท
นายชวลิต ไพโรจน์กุล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
8. ยีนก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับโรคพยาธิใบไม้ตับ: เป้าหมายใหม่สำหรับการป้องกันและรักษา รศ.ดร. นิษณา นามวาท
ผศ.ดร. เรณู ทานันท์
รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อัญชลี เตชะเสน
ศ.ดร. สมชาย ปิ่นละออ
ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
9. ฤทธิ์ของสารยั้บยั้งวิถีการส่งสัญญาณของโปรตีนไคเนสเพื่อใช้ในการป้องกันและรักษาโรคมะเร็งท่อน้ำดี รศ.ดร. วัชรินทร์ ลอยลม
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ศ.ดร. พวงรัตน์ ยงวณิชย์
รศ.ดร. นิษณา นามวาท
อ.ดร. อัญชลี เตชะเสน
ผศ.ดร. เรณู ทานันท์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
10. การประยุกต์ใช้เทคนิค histoculture drug response assays ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี รศ.ดร. วัชรินทร์ ลอยลม
รศ.ดร. นิษณา นามวาท
อ.ดร. อัญชลี เตชะเสน
อ.ดร. อภิญญา จุ๊สกุล
นพ. อรรถพล ติตะปัญ
ม.ล. มานิดา ศุขสวัสดิ
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)
11. การพัฒนาชุดตรวจทางชีวภาพเพื่อใช้ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี รศ.ดร. วัชรินทร์ ลอยลม
อ.ดร. อภิญญา จุ๊สกุล
รศ.ดร. นิษณา นามวาท
อ.ดร. อัญชลี เตชะเสน
ชุดโครงการวิจัย 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)

0.06999039649963379